Global Custom Market Research Reports Provider Company

phone

Infant Bacterial Therapeutics AB (IBT B) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: Sweden
Summary

Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company which develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacillus reuteri, co-evolved human bacterial strain derived from human breast milk, used for the prevention of Necrotizing enterocolitis (NEC); and IBP-1016, a drug candidate used for the treatment of gastroschisis, a severe disease in infants. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal injury, necrosis, perforation in the intestinal tracts of infants and death. It operates through a network of neonatologists and research groups. IBT is headquartered in Stockholm, Sweden.

Infant Bacterial Therapeutics AB Key Recent Developments

Feb 28,2018: Infant Bacterial Therapeutics Interim Management Statement, January 1 December 31, 2017
Jan 17,2018: New Project Manager at IBT
Aug 28,2017: Infant Bacterial Therapeutics: Interim Management Statement, January 1 June 30, 2017
May 04,2017: Infant Bacterial Therapeutics: Interim Management Statement, January 1 March 31, 2017
Mar 10,2017: InfantBacterial Therapeutics has been approved for listing on Nasdaq First Norths Premier segment

This comprehensive SWOT profile of Infant Bacterial Therapeutics AB provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Infant Bacterial Therapeutics AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData


Section 1 - About the Company

Infant Bacterial Therapeutics AB - Key Information
Infant Bacterial Therapeutics AB - Overview
Infant Bacterial Therapeutics AB - Key Employees
Infant Bacterial Therapeutics AB - Key Employee Biographies
Infant Bacterial Therapeutics AB - Key Operational Heads
Infant Bacterial Therapeutics AB - Major Products and Services
Infant Bacterial Therapeutics AB - History
Infant Bacterial Therapeutics AB - Company Statement
Infant Bacterial Therapeutics AB - Locations And Subsidiaries
Infant Bacterial Therapeutics AB - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Infant Bacterial Therapeutics AB - Business Description
Infant Bacterial Therapeutics AB - Corporate Strategy
Infant Bacterial Therapeutics AB - SWOT Analysis
SWOT Analysis - Overview
Infant Bacterial Therapeutics AB - Strengths
Infant Bacterial Therapeutics AB - Weaknesses
Infant Bacterial Therapeutics AB - Opportunities
Infant Bacterial Therapeutics AB - Threats
Infant Bacterial Therapeutics AB - Key Competitors

Section 3 - Company Financial Performance Charts

Infant Bacterial Therapeutics AB - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Infant Bacterial Therapeutics AB, Key Information
Infant Bacterial Therapeutics AB, Key Ratios
Infant Bacterial Therapeutics AB, Share Data
Infant Bacterial Therapeutics AB, Major Products and Services
Infant Bacterial Therapeutics AB, History
Infant Bacterial Therapeutics AB, Key Employees
Infant Bacterial Therapeutics AB, Key Employee Biographies
Infant Bacterial Therapeutics AB, Key Operational Heads
Infant Bacterial Therapeutics AB, Other Locations
Infant Bacterial Therapeutics AB, Subsidiaries
Infant Bacterial Therapeutics AB, Key Manufacturing facilities
Infant Bacterial Therapeutics AB, Key Competitors
Infant Bacterial Therapeutics AB, SWOT Analysis
Infant Bacterial Therapeutics AB, Ratios based on current share price
Infant Bacterial Therapeutics AB, Annual Ratios
Infant Bacterial Therapeutics AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Infant Bacterial Therapeutics AB, Performance Chart
Infant Bacterial Therapeutics AB, Ratio Charts

Baby Food and Infant Formula Baby food products help in fulfilling nutritional requirements of babies and help in their physical growth and development. Infant formula products are fed to babies up

View Report

Report Infant Radiant Warmer-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Infant Radiant Warmer industry, standing on the readers perspective, delivering detailed market data and

View Report

Report Infant Radiant Warmer-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Infant Radiant Warmer industry, standing on the readers perspective, delivering detailed market data and penetrating

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports